Cypress Asset Management’s Boston Scientific BSX Stock Holding History

Cypress Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$298K	Hold	3,122	–	–	0.07%	96
2025 Q3	$305K	Sell	3,122 -28	-0.9%	-$2.9K	0.07%	96
2025 Q2	$338K	Hold	3,150	–	–	0.08%	95
2025 Q1	$318K	Hold	3,150	–	–	0.09%	97
2024 Q4	$281K	Buy	3,150 +150	+5%	+$13.2K	0.07%	99
2024 Q3	$251K	Hold	3,000	–	–	0.06%	100
2024 Q2	$231K	Hold	3,000	–	–	0.06%	98
2024 Q1	$205K	Buy	+3,000	New	+$193K	0.06%	110

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cypress Asset Management's BSX Position: Q4 2025 in Review

Cypress Asset Management held its Boston Scientific (BSX) position steady in Q4 2025 at 3,122 shares worth $298K. The position accounts for 0.07% of the portfolio, ranked #96.

Cypress Asset Management first reported a position in BSX in Q1 2024 and has held it in 8 quarters since. The position peaked at $338K in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Cypress Asset Management held 3,122 shares of Boston Scientific worth $298K as of Q4 2025.
Cypress Asset Management left its Boston Scientific share count unchanged in Q4 2025.
Boston Scientific made up 0.07% of Cypress Asset Management's portfolio in Q4 2025, its #96 holding.
Cypress Asset Management first reported a position in Boston Scientific in Q1 2024 and has held it in 8 quarters since.
Cypress Asset Management's Boston Scientific position peaked at $338K in Q2 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.